Clinical Trials Directory

Trials / Conditions / Gliomas

Gliomas

24 registered clinical trials studyying Gliomas — 6 currently recruiting.

StatusTrialSponsorPhase
RecruitingObservational Study of Responses to Treatments in Advanced Central Nervous System (CNS) Tumors
NCT07374692
National Cancer Institute (NCI)N/A
RecruitingAI-assisted Diagnosis of Malignant Brain Tumors
NCT07198256
Second Affiliated Hospital, School of Medicine, Zhejiang University—
Not Yet RecruitingA Multicentre, Retrospective-prospective Real-world Study: to Evaluate the Effectiveness and Safety of Vorasid
NCT06969352
Servier (Tianjin) Pharmaceutical Co. LTD.—
RecruitingA Single-arm, Open, Exploratory Clinical Study of Allogeneic CAR-T Cells in the Treatment of Relapsed/Refracto
NCT06828341
JIANG LONGWEIEARLY_Phase 1
RecruitingWindow-of-Opportunity Trial of Ulixertinib for MAPK-Activated Gliomas
NCT05804227
M.D. Anderson Cancer CenterEARLY_Phase 1
RecruitingSurgical Suction Aspirates Fluorescence Measurement
NCT06736470
Kuopio University Hospital—
WithdrawnStudy of Laser Interstitial Thermal Therapy (LITT) Treatment Response Assessment With Fluciclovine PET MR
NCT05054400
M.D. Anderson Cancer CenterEARLY_Phase 1
SuspendedStudying the Biology of IDH-mutant Gliomas Via Longitudinal Observation of 2-hydroxyglutarate (2-HG) Using MR
NCT03952598
National Cancer Institute (NCI)Phase 2
CompletedNivolumab for Recurrent or Progressive IDH Mutant Gliomas
NCT03557359
Fabio Iwamoto, MDPhase 2
CompletedChronic Convection Enhanced Delivery of Topotecan
NCT03154996
Jeffrey N. BrucePhase 1
UnknownZOOMit-fMRI Identifies Motor Functional Cortex
NCT03091270
Beijing Neurosurgical Institute—
WithdrawnMore Complete Removal of Malignant Brain Tumors by Fluorescence-Guided Surgery
NCT01445691
Constantinos HadjipanayisPhase 2
TerminatedPhase I/II: Decitabine/Vaccine Therapy in Relapsed/Refractory Pediatric High Grade Gliomas/Medulloblastomas/CN
NCT02332889
University of LouisvillePhase 1 / Phase 2
WithdrawnC11-Sodium Acetate PET/CT Imaging Evaluation in Brain Glioma, Post Therapy Necrosis and Pseudo-progression
NCT01961934
Phoenix Molecular ImagingPhase 2 / Phase 3
CompletedLocation-Molecular Integrated Outcomes in 450 Cerebellar Glioma Microsurgical Cases
NCT07342699
West China Hospital—
UnknownEfficacy of Tranexamic Acid in Brain Tumor Resections
NCT01655927
Colombian Foundation for Epilepsy and Neurological DiseasePhase 3
TerminatedCilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pon
NCT01517776
Martin-Luther-Universität Halle-WittenbergPhase 2
TerminatedA Pilot Study of Inpatient Hospice With Procurement of Brain Tumor Tissue on Expiration for Research Purposes
NCT01251913
National Cancer Institute (NCI)—
CompletedCellular Immunotherapy Study for Brain Cancer
NCT01144247
Jonsson Comprehensive Cancer CenterPhase 1
CompletedAdvanced MR Techniques in Detection of Tumor Infiltration and Grading in Gliomas
NCT01225003
Universitaire Ziekenhuizen KU Leuven—
Completed177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
NCT00967577
Weill Medical College of Cornell UniversityPhase 1
Completed[18F] FACBC and [18F] FLT PET Imaging in Central Nervous System Tumors
NCT00832598
Memorial Sloan Kettering Cancer CenterN/A
CompletedTemozolomide & RT Followed by Dose Dense vs Temozolomide & Retinoic Acid in Pts w/Glioblastoma
NCT00200161
Memorial Sloan Kettering Cancer CenterPhase 2
CompletedA Phase II Study of Adjuvant Use of Anti-Epidermal Growth Factor Receptor EGFR-425 in High Grade Gliomas
NCT00589706
Drexel University College of MedicinePhase 2